Tag: HAS

ISPOR 18th ANNUAL EUROPEAN CONGRESS ISSUE PANEL EXAMINES SYNERGY BETWEEN HTA AND REGULATORY AGENCIES

SESSION EXPLORES OPPORTUNITIES AND CHALLENGES FOR MEDICAL DEVICES Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR 18th ANNUAL EUROPEAN CONGRESS ISSUE PANEL EXPLORES ROLE OF ECONOMIC EVALUATION IN PRICING & REIMBURSEMENT OF MEDICINES

SESSION COMPARES ENGLAND, GERMANY, AND FRANCE  Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress Issue Panel 1 explored, “What Is the Role of Economic Evaluation in Pricing and Reimbursement of

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR’s 1st PLENARY OF 18th ANNUAL EUROPEAN CONGRESS FOCUSES ON LIFECYCLE APPROACH TO DECISION MAKING ON HEALTH TECHNOLOGIES

Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress first plenary session — Strategy in Motion: The Current and Future

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,